We, at OmniActive, invest over 10 per cent of the total outlay into R&D
Express Pharma
DECEMBER 2, 2024
This enables us to optimise dosages in our final products, enhancing both bioavailability and patient safety. Some of our clients have successfully implemented strategies such as displaying supplier logos and QR codes on packaging, allowing consumers to easily access information about the ingredients and clinical results.
Let's personalize your content